Medical Innovation Exchange

MedCity Pivot podcast: Reflecting on the 10-year anniversary of FDA’s approval of transcatheter aortic valve replacement

It has been a decade – this month – that Edwards Lifesciences’ Sapien heart valve was approved by the Food and Drug Administration to non-invasively replace the diseased aortic heart valve for patients who couldn’t undergo open heart surgery.

It was a pivotal moment in treating aortic stenosis, and since then Edwards and Medtronic have introduced various versions and improvements on their respective devices to bring this procedure to more and more people.

This episode of MedCity’s Pivot Podcast features Larry Wood, corporate vice president of TAVR (transcatheter aortic valve replacement) with Edwards who knows the history of this important innovation and believes there is still much to be done in terms of widespread adoption.

Arundhati Parmar

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!